Eli Lilly and Company (English Wikipedia)

"Eli Lilly division to buy Monsanto's cow growth hormone business for $300M". www.bizjournals.com. 20 August 2008. Archived from the original on 1 August 2022. Retrieved 19 March 2022.
"Monsanto to divest bovine growth hormone". www.bizjournals.com. 6 August 2008. Archived from the original on 29 June 2018. Retrieved 23 March 2022.

books.google.com (Global: 3^rd place; English: 3^rd place)

Albert Nelson Marquis, ed. (1916). "Lilly, Josiah Kirby". Who's Who in America: A Biographical Dictionary of Notable Living Men and Women of the United States. A. N. Marquis & Company. p. 1482.
Bliss, Michael (1984). The Discovery of Insulin. University of Chicago Press. ISBN 9780226058986. Archived from the original on 1 August 2022. Retrieved 28 October 2020.
Bliss, Michael (1984). The Discovery of Insulin. University of Chicago Press. pp. 174–175. ISBN 9780226058986. Archived from the original on 28 January 2022. Retrieved 28 October 2020.
Bliss, Michael (1984). The Discovery of Insulin. University of Chicago Press. p. 181. ISBN 9780226058986. Archived from the original on 28 January 2022. Retrieved 28 October 2020.
Current, John D. Pharmacology for Anesthetists:Anesthetics and Adjuvants. Archived from the original on 1 August 2020. Retrieved 19 July 2019.

britannica.com (Global: 40^th place; English: 58^th place)

"Eli Lilly and Company". Encyclopædia Britannica.

camh.ca (Global: low place; English: low place)

"Thank you to our donors" (PDF). Centre for Addiction and Mental Health. 2021. Archived (PDF) from the original on 19 June 2022. Retrieved 1 July 2022.

cbc.ca (Global: 115^th place; English: 82^nd place)

Stastna, Kazi (13 September 2013). "Eli Lilly files $500M NAFTA suit against Canada over drug patents". CBC News. Archived from the original on 26 March 2015.

cbsnews.com (Global: 108^th place; English: 80^th place)

"Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical". CBS News. 23 October 2024.

citeline.com (Global: low place; English: low place)

insights.citeline.com

"LILLY PAYING $85 MIL. FOR FOURTH DEVICE PURCHASE". Citeline. 26 March 1984.
"Eli Lilly sells Pacific Biotech to Quidel (US)". Citeline. 16 January 1995.

clarah.co (Global: low place; English: low place)

Samantha (3 July 2024). "Eli Lilly's Groundbreaking Alzheimer's Drug, Kisunla, Gains FDA Approval". CLARAH.

cnbc.com (Global: 220^th place; English: 155^th place)

Constantino, Annika Kim; Pramuk, Jacob (21 November 2025). "Eli Lilly hits $1 trillion market value, a first in health care, as Novo Nordisk tumbles". CNBC.
"Lilly CEO John Lechleiter to retire; David Ricks named as successor". CNBC. 27 July 2016. Archived from the original on 4 September 2016. Retrieved 10 May 2025.
Constantino, Annika Kim (14 July 2023). "Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion". CNBC. Retrieved 14 July 2023.
Schwartz, Brian (1 June 2021). "Big Pharma lobbyists launch campaign against Biden over Covid vaccine patent waiver". CNBC. Archived from the original on 2 June 2021. Retrieved 8 April 2022.

cnn.com (Global: 28^th place; English: 26^th place)

edition.cnn.com

Hunt, Katie (9 May 2023). "Millions of people are prescribed antidepressants for chronic pain. Do they work?". CNN.

congress.gov (Global: 730^th place; English: 468^th place)

"S.Hrg. 118-198 The Need to Make Insulin Affordable for All Americans". 10 May 2023. Retrieved 18 February 2025.

defense.gov (Global: 1,038^th place; English: 668^th place)

media.defense.gov

"Pharmaceutical Company Eli Lilly to Pay Record $1.415 Billion for Off-Label Drug Marketing" (PDF) (Press release). United States Department of Justice. 15 January 2009.

dhs.gov (Global: 4,767^th place; English: 3,136^th place)

Homeland Security Act 2002, Public Law 107-296 [1] Archived 10 December 2017 at the Wayback Machine

diabetes.ca (Global: low place; English: low place)

"Corporate recognition". Diabetes Canada. February 2021. Archived from the original on 1 May 2022. Retrieved 1 July 2022.

doi.org (Global: 2^nd place; English: 2^nd place)

Nicolaou, Kyriacos C.; Rigol, Stephan (1 February 2018). "A brief history of antibiotics and select advances in their synthesis". The Journal of Antibiotics. 71 (2): 153–184. doi:10.1038/ja.2017.62. ISSN 1881-1469. PMID 28676714.
Toschi, L.; Cappuzzo, F. (2009). "Gemcitabine for the treatment of advanced nonsmall cell lung cancer". OncoTargets and Therapy. 2: 209–217. doi:10.2147/ott.s4645. PMC 2886326. PMID 20616908.
Barton-Burke 1, M (April 1999). "Gemcitabine: a pharmacologic and clinical overview". Cancer Nursing. 22 (2): 176–183. doi:10.1097/00002820-199904000-00011. PMID 10217035.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics". In Mendrick, Donna L.; Mattes, William B. (eds.). Essential Concepts in Toxicogenomics. Methods in Molecular Biology. Vol. 460. pp. 221–238. doi:10.1007/978-1-60327-048-9_11. ISBN 978-1-58829-638-2. PMID 18449490.
Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; et al. (November 2020). "Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic". Drug Discovery Today. 26 (2): 593–603. doi:10.1016/j.drudis.2020.11.025. PMC 7694556. PMID 33253920.
Leslie, Laurel K.; Newman, Thomas B.; Chesney, P. Joan; Perrin, James M. (1 July 2005). "The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients". Pediatrics. 116 (1): 195–204. doi:10.1542/peds.2005-0074. PMC 1550709. PMID 15995053.
Fornaro, Michele; Anastasia, Annalisa; Valchera, Alessandro; Carano, Alessandro; Orsolini, Laura; Vellante, Federica; et al. (3 May 2019). "The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?". Frontiers in Psychiatry. 10 294. doi:10.3389/fpsyt.2019.00294. PMC 6510161. PMID 31130881.

drugwatch.com (Global: low place; English: low place)

"Prozac Litigation - Link to Suicide, Birth Defects & Class Action". Drugwatch.com. Archived from the original on 21 March 2022. Retrieved 20 March 2022.

elanco.com (Global: low place; English: low place)

investor.elanco.com

"Elanco Animal Health Completes Separation from Lilly" (Press release). Elanco. 11 March 2019.

endocrine.org (Global: low place; English: low place)

"Corporate Liaison Board". Endocrine Society. Archived from the original on 10 June 2022. Retrieved 10 June 2022.

endpts.com (Global: low place; English: low place)

Tong, Amber (14 February 2022). "As Omicron rages, FDA clears Eli Lilly/AbCellera's new antibody days after $720M supply deal". Endpoints News. Archived from the original on 15 February 2022. Retrieved 1 July 2022.

escardio.org (Global: low place; English: low place)

"Why sponsor the EURObservational Registry Programme". European Society of Cardiology. Archived from the original on 15 June 2022. Retrieved 15 June 2022.

europa.eu (Global: 68^th place; English: 117^th place)

imi.europa.eu

"The Innovative Medicines Initiative". Innovative Medicines Initiative. Archived from the original on 20 January 2013.

fda.gov (Global: 447^th place; English: 338^th place)

"Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19". U.S. Food and Drug Administration (FDA) (Press release). 9 November 2020. Archived from the original on 11 January 2021.
"Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab". Food and Drug Administration (FDA) (Press release). 16 April 2021. Archived from the original on 16 April 2021. This article incorporates text from this source, which is in the public domain.
"FDA Approves New Medication for Chronic Weight Management". FDA (Press release). 3 November 2023. Retrieved 7 April 2024.
"Suicidality in Children and Adolescents Being Treated With Antidepressant Medications". FDA. 3 November 2018. Archived from the original on 23 August 2020.

fdocuments.in (Global: low place; English: low place)

"The 8th Princess Margaret Hospital Conference: Developments in Cancer Management". FDocuments India. Archived from the original on 20 June 2022. Retrieved 1 July 2022.

fiercebiotech.com (Global: low place; English: 8,828^th place)

"PRESS RELEASE: Lilly Sells Former ICOS Biologics Operation" (Press release). FierceBiotech. 4 December 2007.

fiercepharma.com (Global: low place; English: 8,921^st place)

Staton, Tracy (15 January 2009). "Lilly to pay $1.4B in Zyprexa settlement". Fierce Pharma. Questex.
"Lilly, Innovent's Tyvyt nabs FDA review in front-line lung cancer. Could price pressure finally reach the PD-1/L1 class?". Fierce Pharma. 18 May 2021. Archived from the original on 20 August 2021. Retrieved 23 April 2022.
Higgins-Dunn, Noah (30 June 2021). "Amid rush of scandals, Eli Lilly settles sex discrimination, harassment suit with former lobbyist". Fierce Pharma. Archived from the original on 30 June 2021. Retrieved 20 March 2022.

financialpost.com (Global: 3,491^st place; English: 1,999^th place)

Melnitzer, Julius (27 March 2017). "Eli Lilly loses NAFTA challenge brought against Canada". Financial Post.

fnih.org (Global: low place; English: low place)

2020-annual-report.fnih.org

"2020 Donors". FNIH 2020 Annual Report. Archived from the original on 2 April 2022. Retrieved 6 April 2022.

forbes.com (Global: 54^th place; English: 48^th place)

"Forbes: Eli Lilly and Company". Forbes.
"Eli Lilly is Facing a Lawsuit Alleging A 'Sexually Hostile Work Environment' from a Former Lobbyist". Forbes. Archived from the original on 1 August 2022. Retrieved 20 March 2022.
Lee, Bruce Y. (12 November 2022). "Fake Eli Lilly Twitter Account Claims Insulin Is Free, Stock Falls 4.37%". Forbes. Archived from the original on 14 November 2022.
Dellatto, Marisa (10 November 2022). "Eli Lilly Clarifies It's Not Offering Free Insulin After Tweet From Fake Verified Account—As Chaos Unfolds On Twitter". Forbes. Archived from the original on 14 November 2022.

ford.com (Global: 2,073^rd place; English: 1,349^th place)

media.ford.com

"John C. Lechleiter, PH.D." Ford Motor Company.

fortune.com (Global: 433^rd place; English: 284^th place)

"Fortune 500: Eli Lilly and Company". Fortune.

ft.com (Global: 210^th place; English: 157^th place)

"Eli Lilly in storm over Prozac evidence". Financial Times. 30 December 2004. Archived from the original on 20 March 2022. Retrieved 20 March 2022.

genengnews.com (Global: low place; English: 6,625^th place)

"Eli Lilly to Co-Develop Hanmi BTK Inhibitor for Up-to-$690M". Genetic Engineering & Biotechnology News. 19 March 2015.
"Lilly Joins Innovent in Up-to-$456M+ Cancer Collaboration". Genetic Engineering & Biotechnology News. 20 March 2015. Archived from the original on 23 April 2015.
Philippidis, Alex (23 March 2015). "Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program". Genetic Engineering & Biotechnology News. Archived from the original on 14 November 2017.
"Lilly to Buy CoLucid for $960M to Acquire Late-Stage Migraine Drug". Genetic Engineering & Biotechnology News. 18 January 2017. Archived from the original on 19 January 2017.
"Lilly Continues Oncology Expansion with Plans to Buy AurKa Pharma for Up to $575M". Genetic Engineering & Biotechnology News. 14 May 2018. Archived from the original on 12 June 2018.

healthcarefinancenews.com (Global: low place; English: low place)

"Eli Lilly files motion to prevent giving 340B drug discounts to contract pharmacies". Healthcare Finance News. 25 May 2021. Archived from the original on 7 July 2021. Retrieved 20 March 2022.

hematology.org (Global: low place; English: low place)

"Corporate Support". American Society of Hematology. 2022. Archived from the original on 10 June 2022. Retrieved 1 July 2022.

hopeww.org (Global: low place; English: low place)

"Partners". HOPE Worldwide. 2022. Archived from the original on 11 May 2022. Retrieved 1 July 2022.

ifpma.org (Global: low place; English: low place)

"Companies". International Federation of Pharmaceutical Manufacturers and Associations. Archived from the original on 1 July 2022. Retrieved 1 July 2022.

in.gov (Global: 3,146^th place; English: 1,695^th place)

in.gov

"Colonel Eli Lilly (1838–1898)" (PDF). Lilly Archives. January 2008. Archived (PDF) from the original on 18 November 2016.

secure.in.gov

"Indiana State Historic Architectural and Archaeological Research Database (SHAARD)" (Searchable database). Department of Natural Resources, Division of Historic Preservation and Archaeology. Archived from the original on 23 November 2018. Retrieved 1 April 2016. Note: This includes Eugene F. Rodman (April 1976). "National Register of Historic Places Inventory Nomination Form: Lilly Biological Laboratories" (PDF). Archived (PDF) from the original on 28 February 2017. Retrieved 1 April 2016. and Accompanying photographs.

independent.co.uk (Global: 36^th place; English: 33^rd place)

Black, Larry (18 January 1994). "Eli Lilly to cut divisions free and put drugs first". The Independent.

indianahistory.org (Global: low place; English: low place)

"Eli Lilly & Company" (PDF). Indianapolis: Indiana Historical Society. p. 1. Archived from the original (PDF) on 29 July 2016. Retrieved 26 February 2013.
"Eli Lilly & Company". Indiana Historical Society. 18 September 2017.
"Eli Lilly & Company" (PDF). pp. 2, 5 and 6. Archived from the original (PDF) on 29 July 2016. Retrieved 26 February 2013.
"Eli Lilly and Company and the Salk Polio Vaccine" (PDF). Indiana Historical Society.

indystar.com (Global: 1,646^th place; English: 896^th place)

Swiatek, Jeff (28 December 2015). "10 all-time greatest Eli Lilly drugs". The Indianapolis Star. Archived from the original on 1 August 2022. Retrieved 13 November 2017.

informa.com (Global: low place; English: low place)

scrip.pharmaintelligence.informa.com

"Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players". Script. 11 January 2023. Retrieved 18 June 2023.

innovativemedicines.ca (Global: low place; English: low place)

"Member Companies". Innovative Medicines Canada. Archived from the original on 3 November 2021. Retrieved 8 March 2022.

issuu.com (Global: 537^th place; English: 476^th place)

The Indiana Historical Society recreated a replica of the first Lilly laboratory on Pearl Street for its exhibition, "You Are There: Eli Lilly at the Beginning," at the Eugene and Marilyn Glick Indiana History Center in Indianapolis. The temporary exhibition (1 October 2016, to 20 January 2018) also included costumed interpreters portraying Colonel Lilly and others. See "The Man Behind State's Most Successful Startup". Kendallville New Sun. Kendallville, Indiana: KPC News. 9 September 2016. Archived from the original on 4 August 2020. See also Alvarez, Tom, ed. (Fall 2016). "Fall Arts Guide". UNITE Indianapolis. Indianapolis: Joey Amato: 32. Archived from the original on 12 January 2017. Retrieved 24 October 2016.

iu.edu (Global: 3,316^th place; English: 1,982^nd place)

tobiascenter.iu.edu

"Randall L. Tobias". Indiana University.

jdrf.ca (Global: low place; English: low place)

"Our Corporate Partners". JDRF Canada. Archived from the original on 12 March 2022. Retrieved 1 July 2022.

jstor.org (Global: 26^th place; English: 20^th place)

Madison, James H. (1989). "Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876–1948". Business and Economic History. 18. Business History Conference: 72–78. JSTOR 23702883.

justice.gov (Global: 918^th place; English: 556^th place)

"Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa". 09-civ-038. United States Department of Justice. 15 January 2009. Archived from the original on 13 March 2016. Retrieved 22 November 2020.
"#05-685: 12-21-05 Eli Lilly and Company to Pay U.S. $36 Million Relating to Off-Label Promotion". www.justice.gov. Archived from the original on 20 March 2022. Retrieved 20 March 2022.

kpcnews.com (Global: low place; English: low place)

The Indiana Historical Society recreated a replica of the first Lilly laboratory on Pearl Street for its exhibition, "You Are There: Eli Lilly at the Beginning," at the Eugene and Marilyn Glick Indiana History Center in Indianapolis. The temporary exhibition (1 October 2016, to 20 January 2018) also included costumed interpreters portraying Colonel Lilly and others. See "The Man Behind State's Most Successful Startup". Kendallville New Sun. Kendallville, Indiana: KPC News. 9 September 2016. Archived from the original on 4 August 2020. See also Alvarez, Tom, ed. (Fall 2016). "Fall Arts Guide". UNITE Indianapolis. Indianapolis: Joey Amato: 32. Archived from the original on 12 January 2017. Retrieved 24 October 2016.

latimes.com (Global: 22^nd place; English: 19^th place)

"Eli Lilly to Acquire California company". Los Angeles Times. 7 December 1988.
"Dow to Buy Lilly's 40% Stake in Dow Elanco". Los Angeles Times. Reuters. 16 May 1997. Archived from the original on 1 August 2022. Retrieved 13 November 2017.

lilly.com (Global: low place; English: low place)

investor.lilly.com

"Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans". Lilly. 1 June 2020. Archived from the original on 4 June 2020. Retrieved 4 June 2020.
"Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases" (Press release). Eli Lilly. 14 July 2023. Retrieved 14 July 2023.

lilly.com

"Lilly Statement Regarding NIH's ACTIV-3 Clinical Trial". Eli Lilly and Company (Press release). 26 October 2020. Archived from the original on 16 January 2021. Retrieved 26 October 2020.
"Lilly.com". Eli Lilly and Company. Archived from the original on 1 August 2022. Retrieved 20 March 2022.

lobbycanada.gc.ca (Global: low place; English: low place)

"Innovative Medicines Canada/Médicaments Novateurs Canada / Andrew Balfour, Consultant". Registry of Lobbyists. 28 March 2022. Archived from the original on 8 April 2022. Retrieved 8 April 2022.

macleans.ca (Global: 1,824^th place; English: 1,065^th place)

Maher, Stephen (29 January 2019). "For access to the Ford government, two names matter most". MacLean's. Archived from the original on 22 March 2021. Retrieved 8 March 2022.

marketwatch.com (Global: 1,303^rd place; English: 808^th place)

"Eli Lilly, ICOS team up for impotency drug 10-1-98". MarketWatch. 1 October 1998.

nationalhealthcouncil.org (Global: low place; English: low place)

"Our Members". National Health Council. Archived from the original on 6 April 2022. Retrieved 6 April 2022.

nationalpress.org (Global: low place; English: low place)

"Our Funders". National Press Foundation. 2013. Archived from the original on 28 January 2013. Retrieved 1 July 2022.

nbcnews.com (Global: 137^th place; English: 101^st place)

Lovelace Jr., Berkeley (March 2023). "Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions". NBC News. NBC Universal. Retrieved 1 March 2023.
"Eli Lilly settles Zyprexa lawsuit for $1.42 billion". NBC News. Associated Press. 15 January 2009. Archived from the original on 23 August 2022.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

O'Donnell, J.; Vogenberg, F. R. (2011). "Applying Legal Risk Management to the Clinical Use of Methadone". P & T: A Peer-Reviewed Journal for Formulary Management. 36 (12): 813–822. PMC 3278176. PMID 22346315.
Nicolaou, Kyriacos C.; Rigol, Stephan (1 February 2018). "A brief history of antibiotics and select advances in their synthesis". The Journal of Antibiotics. 71 (2): 153–184. doi:10.1038/ja.2017.62. ISSN 1881-1469. PMID 28676714.
Toschi, L.; Cappuzzo, F. (2009). "Gemcitabine for the treatment of advanced nonsmall cell lung cancer". OncoTargets and Therapy. 2: 209–217. doi:10.2147/ott.s4645. PMC 2886326. PMID 20616908.
Barton-Burke 1, M (April 1999). "Gemcitabine: a pharmacologic and clinical overview". Cancer Nursing. 22 (2): 176–183. doi:10.1097/00002820-199904000-00011. PMID 10217035.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics". In Mendrick, Donna L.; Mattes, William B. (eds.). Essential Concepts in Toxicogenomics. Methods in Molecular Biology. Vol. 460. pp. 221–238. doi:10.1007/978-1-60327-048-9_11. ISBN 978-1-58829-638-2. PMID 18449490.
Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; et al. (November 2020). "Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic". Drug Discovery Today. 26 (2): 593–603. doi:10.1016/j.drudis.2020.11.025. PMC 7694556. PMID 33253920.
Leslie, Laurel K.; Newman, Thomas B.; Chesney, P. Joan; Perrin, James M. (1 July 2005). "The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients". Pediatrics. 116 (1): 195–204. doi:10.1542/peds.2005-0074. PMC 1550709. PMID 15995053.
Fornaro, Michele; Anastasia, Annalisa; Valchera, Alessandro; Carano, Alessandro; Orsolini, Laura; Vellante, Federica; et al. (3 May 2019). "The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?". Frontiers in Psychiatry. 10 294. doi:10.3389/fpsyt.2019.00294. PMC 6510161. PMID 31130881.

ncbi.nlm.nih.gov

O'Donnell, J.; Vogenberg, F. R. (2011). "Applying Legal Risk Management to the Clinical Use of Methadone". P & T: A Peer-Reviewed Journal for Formulary Management. 36 (12): 813–822. PMC 3278176. PMID 22346315.
Toschi, L.; Cappuzzo, F. (2009). "Gemcitabine for the treatment of advanced nonsmall cell lung cancer". OncoTargets and Therapy. 2: 209–217. doi:10.2147/ott.s4645. PMC 2886326. PMID 20616908.
Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; et al. (November 2020). "Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic". Drug Discovery Today. 26 (2): 593–603. doi:10.1016/j.drudis.2020.11.025. PMC 7694556. PMID 33253920.
Leslie, Laurel K.; Newman, Thomas B.; Chesney, P. Joan; Perrin, James M. (1 July 2005). "The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients". Pediatrics. 116 (1): 195–204. doi:10.1542/peds.2005-0074. PMC 1550709. PMID 15995053.
Fornaro, Michele; Anastasia, Annalisa; Valchera, Alessandro; Carano, Alessandro; Orsolini, Laura; Vellante, Federica; et al. (3 May 2019). "The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?". Frontiers in Psychiatry. 10 294. doi:10.3389/fpsyt.2019.00294. PMC 6510161. PMID 31130881.

dailymed.nlm.nih.gov

"Zepbound- tirzepatide injection, solution". DailyMed. 9 November 2023. Archived from the original on 20 November 2023. Retrieved 20 November 2023.

nosm.ca (Global: low place; English: low place)

"Donor Wall". Northern Ontario School of Medicine. Archived from the original on 19 June 2022. Retrieved 1 July 2022.

nytimes.com (Global: 7^th place; English: 7^th place)

Pollack, Andrew (30 April 2005). "Lizard-Derived Diabetes Drug Is Approved by the F.D.A.". The New York Times.
"Eugene N. Beesley Dead at 67;Ex-Chairman of Eli Lilly &Co". The New York Times. 9 February 1976.
"COMPANY NEWS; Lilly Finishes Sale Of Its Arden Unit". The New York Times. Associated Press. 23 December 1987.
"Eli Lilly Signs Agreement To Acquire Ivac Corp". The New York Times. 14 October 1977. Archived from the original on 15 June 2018.
"COMPANY NEWS; ELI LILLY AGREES TO SELL DIAGNOSTICS SUBSIDIARY". The New York Times. Associated Press. 30 September 1995.
"Eli Lilly Acquires Laparoscope Unit". The New York Times. Associated Press. 25 February 1992.
Haberman, Clyde (21 September 2014). "Selling Prozac as the Life-Enhancing Cure for Mental Woes". The New York Times.
Freudenheim, Milt (4 November 1994). "Eli Lilly Deal Is Approved By the F.T.C.". The New York Times.
Wilson, Duff (2 October 2010). "Side Effects May Include Lawsuits". The New York Times. Archived from the original on 25 April 2011.
Pollack, Andrew (2 October 1998). "Lilly Pays Big Fee Up Front To Share in Rival of Viagra". The New York Times.
Pollack, Andrew (21 September 2002). "Eli Lilly in Deal For the Rights To a New Drug For Diabetes". The New York Times.
"Lilly Increases Offer for Icos; Shareholders' Vote Is Put Off". The New York Times. Associated Press. 19 December 2006. Archived from the original on 3 June 2013. Retrieved 27 February 2013.
Thomas, Katie (8 October 2020). "Regeneron Asks F.D.A. for Emergency Approval for Drug That Trump C7laimed Cured Him". The New York Times. ISSN 0362-4331. Archived from the original on 8 October 2020.
Kelley, Lora (6 August 2022). "Major Indiana Employers Criticize State's New Abortion Law". The New York Times. ISSN 0362-4331. Archived from the original on 7 August 2022. Retrieved 7 August 2022.
Angier, Natalie (16 August 1990). "HEALTH; Eli Lilly Facing Million-Dollar Suits On Its Antidepressant Drug Prozac". The New York Times. ISSN 0362-4331. Archived from the original on 20 March 2022. Retrieved 20 March 2022.
Berenson A (5 January 2007). "Lilly Settles With 18,000 Over Zyprexa". The New York Times. Archived from the original on 19 February 2017. Retrieved 20 March 2022.
Berenson A (4 January 2007). "Mother Wonders if Psychosis Drug Helped Kill Son". The New York Times. Archived from the original on 1 September 2012. Retrieved 21 May 2013.
Berenson A (26 March 2008). "Lilly Settles Alaska Suit Over Zyprexa". The New York Times. Archived from the original on 15 February 2017. Retrieved 2 August 2022.
Harris G, Berenson A (14 January 2009). "Lilly Said to Be Near $1.4 Billion U.S. Settlement". The New York Times. Archived from the original on 19 February 2017. Retrieved 2 August 2022.
Wilson, Duff (2 October 2010). "Side Effects May Include Lawsuits". The New York Times. Archived from the original on 25 April 2011. Retrieved 23 September 2011.
Berenson, Alex (15 March 2008). "Eli Lilly E-Mail Discussed Unapproved Use of Drug". The New York Times. Archived from the original on 1 August 2022. Retrieved 24 August 2015.
Robbins, Rebecca (1 March 2023). "Eli Lilly Says It Will Cut the Price of Insulin". The New York Times.

oico.on.ca (Global: low place; English: low place)

lobbyist.oico.on.ca

"Consultant Lobbyist Registration No. CL4899-20200917025456". Office of the Integrity Commissioner of Ontario. 22 September 2021. Archived from the original on 8 March 2022. Retrieved 8 March 2022.

opensecrets.org (Global: 4,705^th place; English: 2,665^th place)

"Client Profile: Eli Lilly & Co". OpenSecrets.

ophirex.com (Global: low place; English: low place)

"Ophirex Licenses Lilly – Shionogi Data for Novel Snakebite Treatment Development Program" (Press release). Ophirex. 28 August 2017.

ourcommons.ca (Global: low place; English: 8,086^th place)

"Evidence - CIIT (43-2) - No. 25". House of Commons of Canada. 23 April 2021. Archived from the original on 8 March 2022. Retrieved 1 July 2022.

phri.ca (Global: low place; English: low place)

"Collaborations". Population Health Research Institute of Canada. 2022. Archived from the original on 12 June 2022. Retrieved 1 July 2022.

phrma.org (Global: low place; English: low place)

"About". PhRMA. Archived from the original on 6 April 2022. Retrieved 6 April 2022.

pmlive.com (Global: low place; English: low place)

Meek, Tom (19 May 2014). "This month in 1876: Creation of Eli Lilly & Company". PM Live.

prnewswire.com (Global: 406^th place; English: 258^th place)

"Lilly to Separate Elanco Animal Health with Initial Public Offering" (Press release). Lilly. 24 July 2018 – via PR Newswire.
"Elanco Animal Health Completes Acquisition of Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio" (Press release). Elanco. 3 January 2017 – via PR Newswire.

psychiatrictimes.com (Global: 9,815^th place; English: 7,507^th place)

"The Fight for Pharma Accountability and Psychiatric Rights: Jim Gottstein, Esq". Psychiatric Times. 2 August 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.

reuters.com (Global: 49^th place; English: 47^th place)

Sen, Arnab (22 April 2014). Warrier, Gopakumar (ed.). "Eli Lilly to buy Novartis' animal health unit for $5.4 billion". Reuters. Archived from the original on 28 December 2015. Retrieved 21 April 2015.
Bartz, Diane (22 December 2014). Benkoe, Jeffrey; Baum, Bernadette (eds.). "Lilly must divest Sentinel products after FTC nod on Novartis deal". Reuters. Archived from the original on 28 January 2022. Retrieved 5 July 2021.
Mishra, Manas (10 May 2018). "Lilly to buy Armo Biosciences for $1.6 billion to bolster cancer pipeline". Reuters. Archived from the original on 9 June 2018.
"Lilly to buy cancer drug developer AurKa Pharma". Reuters. 14 May 2018.
Burger, Ludwig (20 August 2019). "Elanco to buy Bayer's animal health unit for $7.6 billion". Reuters. Archived from the original on 20 August 2019.
"Elanco to become No.2 in animal health with $7.6 billion Bayer deal". Reuters. 20 August 2019.
"Eli Lilly to buy gene therapy developer Prevail in about $1 billion deal". Reuters. 15 December 2020.
"Eli Lilly to buy gene therapy company Akouos for $487 mln". Reuters. 18 October 2022. Archived from the original on 19 October 2022.
Leo, Leroy; Satija, Bhanvi (3 October 2023). Kalluvila, Sriraj (ed.). "Eli Lilly to buy cancer-focused Point Biopharma for $1.4 billion". Reuters.
"UK approves Lilly's Alzheimer's drug, but deemed 'too expensive' for wide use". Reuters. 23 October 2024.
"Eli Lilly boosts immunology business with $2.4 billion deal for Dice". Reuters. 20 June 2023.
Abutaleb, Yasmeen (30 January 2019). "U.S. lawmakers request info from insulin makers on rising prices". Reuters. Archived from the original on 31 January 2019.
Ward, Jasper; Acharya, Bhargav; Roy, Mrinalika (12 August 2025). Barona, Alan (ed.). "Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications". Reuters.

sciencehistory.org (Global: 3,963^rd place; English: 2,357^th place)

Roberts, Jacob (2015). "Sickening sweet". Distillations. 1 (4): 12–15. Archived from the original on 13 November 2019. Retrieved 20 March 2018.

seattlepi.com (Global: 1,215^th place; English: 726^th place)

James, Andrea (26 January 2007). "Icos Voters Approve Buyout by Eli Lilly". Seattle Post-Intelligencer. Archived from the original on 1 August 2022.

seattletimes.com (Global: 519^th place; English: 316^th place)

archive.seattletimes.com

Timmerman, Luke (7 November 2006). "Proposed Icos Sale Gets More Criticism: Payouts for Execs Called 'Overkill'". The Seattle Times. Archived from the original on 12 June 2012.

sec.gov (Global: 572^nd place; English: 436^th place)

"Eli Lilly and Company 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 19 February 2025.
"Eli Lilly and Company 2023 Proxy Statement (Form DEF 14A)". U.S. Securities and Exchange Commission. 17 March 2023. Retrieved 21 February 2024.

shnfoundation.ca (Global: low place; English: low place)

"Our Donors". Scarborough Health Network Foundation. 2021. Archived from the original on 20 June 2022. Retrieved 1 July 2022.

sickkidsfoundation.com (Global: low place; English: low place)

web.sickkidsfoundation.com

"2020-21 SickKids Annual Report". SickKids Foundation. 2021. Archived from the original on 20 June 2022. Retrieved 1 July 2022.

sinaihealthannualreport.ca (Global: low place; English: low place)

"Donor List - Cumulative". Sinai Health Annual Report. 31 March 2021. Archived from the original on 20 June 2022. Retrieved 1 July 2022.

statnews.com (Global: 8,771^st place; English: 5,253^rd place)

Facher, Lev (1 February 2024). "Methadone treatment gets first major update in over 20 years". Stat.
Herper, Matthew (7 October 2020). "Eli Lilly says its monoclonal antibody cocktail is effective against Covid-19". Stat News. Archived from the original on 8 October 2020.

sunnybrook.ca (Global: low place; English: low place)

"Our donors - Your Impact". Sunnybrook Foundation. 2022. Archived from the original on 20 June 2022. Retrieved 1 July 2022.

theguardian.com (Global: 12^th place; English: 11^th place)

Tomlinson, Heather (25 November 2003). "Eli Lilly launches '48-hour' Viagra rival". The Guardian.

thepmcf.ca (Global: low place; English: low place)

"2021 Annual Report" (PDF). Princess Margaret Cancer Foundation. 2021. Archived (PDF) from the original on 20 November 2021. Retrieved 1 July 2022.

thestar.com (Global: 336^th place; English: 216^th place)

Jiang, Kevin (11 November 2022). "Eli Lilly loses billions in market cap after 'verified' Twitter impostor promises free insulin". Toronto Star. Archived from the original on 14 November 2022. Retrieved 14 November 2022.

thetimes.com (Global: low place; English: low place)

Pagnamenta, Robin (23 January 2007). "Eli Lilly was concerned by Zyprexa side-effects from 1998". The Times. Archived from the original on 20 February 2007.

thezyprexapapers.com (Global: low place; English: low place)

Gottstein, James (2021). The Zyreza Papers. Samizdat Health Writer's Cooperative 2021. https://thezyprexapapers.com/ Archived 4 April 2022 at the Wayback Machine. Retrieved 21-10-26.

trex.bio (Global: low place; English: low place)

"TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases". TRex Bio. 9 January 2023. Retrieved 18 June 2023.

upi.com (Global: 290^th place; English: 202^nd place)

"Eli Lilly to separate two units from pharmaceutical business". United Press International. 18 January 1994.
"Lilly to purchase PCS for $4 billion". United Press International. 11 July 1994.

usatoday.com (Global: 41^st place; English: 34^th place)

Wolfson, Andrew. "Prozac maker paid millions to secure favorable verdict in mass shooting lawsuit, victims say". USA TODAY. Archived from the original on 20 October 2022. Retrieved 20 March 2022.

utoronto.ca (Global: 1,601^st place; English: 1,117^th place)

insulin.library.utoronto.ca

Hutchison, F. Lorne (18 October 1924). "Notes on the history of the Insulin Committee's objection to Lilly's use of the term Iletin". University of Toronto Libraries. Archived from the original on 20 June 2019. Retrieved 20 June 2019.
"Insulin wins a great prize". University of Toronto Libraries. New York, NY: Literary Digest. 8 December 1923. Archived from the original on 20 June 2019. Retrieved 20 June 2019.
"Citation to F. G. Banting and J. J. R. Macleod accompanying the Nobel Prize". University of Toronto Libraries. Stockholm, Sweden: Royal Karolinska Institute. 1923. Archived from the original on 30 May 2019. Retrieved 20 June 2019.

connaught.research.utoronto.ca

Rutty, Christopher J. "Connaught Laboratories & The Making of Insulin". Connaught Fund. Archived from the original on 28 June 2019. Retrieved 20 June 2019.

boundless.utoronto.ca

"Donor Listing". University of Toronto. Archived from the original on 30 May 2022. Retrieved 1 July 2022.

engage.utoronto.ca

"Presidents' Circle Member Listing". University of Toronto. 1 May 2022. Archived from the original on 16 May 2022. Retrieved 1 July 2022.

web.archive.org (Global: 1^st place; English: 1^st place)

Swiatek, Jeff (28 December 2015). "10 all-time greatest Eli Lilly drugs". The Indianapolis Star. Archived from the original on 1 August 2022. Retrieved 13 November 2017.
"Zepbound- tirzepatide injection, solution". DailyMed. 9 November 2023. Archived from the original on 20 November 2023. Retrieved 20 November 2023.
"Eli Lilly & Company" (PDF). Indianapolis: Indiana Historical Society. p. 1. Archived from the original (PDF) on 29 July 2016. Retrieved 26 February 2013.
"Colonel Eli Lilly (1838–1898)" (PDF). Lilly Archives. January 2008. Archived (PDF) from the original on 18 November 2016.
The Indiana Historical Society recreated a replica of the first Lilly laboratory on Pearl Street for its exhibition, "You Are There: Eli Lilly at the Beginning," at the Eugene and Marilyn Glick Indiana History Center in Indianapolis. The temporary exhibition (1 October 2016, to 20 January 2018) also included costumed interpreters portraying Colonel Lilly and others. See "The Man Behind State's Most Successful Startup". Kendallville New Sun. Kendallville, Indiana: KPC News. 9 September 2016. Archived from the original on 4 August 2020. See also Alvarez, Tom, ed. (Fall 2016). "Fall Arts Guide". UNITE Indianapolis. Indianapolis: Joey Amato: 32. Archived from the original on 12 January 2017. Retrieved 24 October 2016.
"Indiana State Historic Architectural and Archaeological Research Database (SHAARD)" (Searchable database). Department of Natural Resources, Division of Historic Preservation and Archaeology. Archived from the original on 23 November 2018. Retrieved 1 April 2016. Note: This includes Eugene F. Rodman (April 1976). "National Register of Historic Places Inventory Nomination Form: Lilly Biological Laboratories" (PDF). Archived (PDF) from the original on 28 February 2017. Retrieved 1 April 2016. and Accompanying photographs.
Bliss, Michael (1984). The Discovery of Insulin. University of Chicago Press. ISBN 9780226058986. Archived from the original on 1 August 2022. Retrieved 28 October 2020.
Rutty, Christopher J. "Connaught Laboratories & The Making of Insulin". Connaught Fund. Archived from the original on 28 June 2019. Retrieved 20 June 2019.
Roberts, Jacob (2015). "Sickening sweet". Distillations. 1 (4): 12–15. Archived from the original on 13 November 2019. Retrieved 20 March 2018.
Bliss, Michael (1984). The Discovery of Insulin. University of Chicago Press. pp. 174–175. ISBN 9780226058986. Archived from the original on 28 January 2022. Retrieved 28 October 2020.
Hutchison, F. Lorne (18 October 1924). "Notes on the history of the Insulin Committee's objection to Lilly's use of the term Iletin". University of Toronto Libraries. Archived from the original on 20 June 2019. Retrieved 20 June 2019.
"Insulin wins a great prize". University of Toronto Libraries. New York, NY: Literary Digest. 8 December 1923. Archived from the original on 20 June 2019. Retrieved 20 June 2019.
"Citation to F. G. Banting and J. J. R. Macleod accompanying the Nobel Prize". University of Toronto Libraries. Stockholm, Sweden: Royal Karolinska Institute. 1923. Archived from the original on 30 May 2019. Retrieved 20 June 2019.
Bliss, Michael (1984). The Discovery of Insulin. University of Chicago Press. p. 181. ISBN 9780226058986. Archived from the original on 28 January 2022. Retrieved 28 October 2020.
"Eli Lilly & Company" (PDF). pp. 2, 5 and 6. Archived from the original (PDF) on 29 July 2016. Retrieved 26 February 2013.
Homeland Security Act 2002, Public Law 107-296 [1] Archived 10 December 2017 at the Wayback Machine
Current, John D. Pharmacology for Anesthetists:Anesthetics and Adjuvants. Archived from the original on 1 August 2020. Retrieved 19 July 2019.
Hagerty, James R. (3 May 2020). "Eli Lilly CEO Richard Wood Oversaw Prozac Launch". The Wall Street Journal. Archived from the original on 23 May 2020.
"Eli Lilly Signs Agreement To Acquire Ivac Corp". The New York Times. 14 October 1977. Archived from the original on 15 June 2018.
"Dow to Buy Lilly's 40% Stake in Dow Elanco". Los Angeles Times. Reuters. 16 May 1997. Archived from the original on 1 August 2022. Retrieved 13 November 2017.
Wilson, Duff (2 October 2010). "Side Effects May Include Lawsuits". The New York Times. Archived from the original on 25 April 2011.
"Lilly Increases Offer for Icos; Shareholders' Vote Is Put Off". The New York Times. Associated Press. 19 December 2006. Archived from the original on 3 June 2013. Retrieved 27 February 2013.
Timmerman, Luke (7 November 2006). "Proposed Icos Sale Gets More Criticism: Payouts for Execs Called 'Overkill'". The Seattle Times. Archived from the original on 12 June 2012.
James, Andrea (26 January 2007). "Icos Voters Approve Buyout by Eli Lilly". Seattle Post-Intelligencer. Archived from the original on 1 August 2022.
"The Innovative Medicines Initiative". Innovative Medicines Initiative. Archived from the original on 20 January 2013.
"Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa". 09-civ-038. United States Department of Justice. 15 January 2009. Archived from the original on 13 March 2016. Retrieved 22 November 2020.
Sen, Arnab (22 April 2014). Warrier, Gopakumar (ed.). "Eli Lilly to buy Novartis' animal health unit for $5.4 billion". Reuters. Archived from the original on 28 December 2015. Retrieved 21 April 2015.
Bartz, Diane (22 December 2014). Benkoe, Jeffrey; Baum, Bernadette (eds.). "Lilly must divest Sentinel products after FTC nod on Novartis deal". Reuters. Archived from the original on 28 January 2022. Retrieved 5 July 2021.
"Lilly Joins Innovent in Up-to-$456M+ Cancer Collaboration". Genetic Engineering & Biotechnology News. 20 March 2015. Archived from the original on 23 April 2015.
Philippidis, Alex (23 March 2015). "Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program". Genetic Engineering & Biotechnology News. Archived from the original on 14 November 2017.
"Lilly CEO John Lechleiter to retire; David Ricks named as successor". CNBC. 27 July 2016. Archived from the original on 4 September 2016. Retrieved 10 May 2025.
"Lilly to Buy CoLucid for $960M to Acquire Late-Stage Migraine Drug". Genetic Engineering & Biotechnology News. 18 January 2017. Archived from the original on 19 January 2017.
Mishra, Manas (10 May 2018). "Lilly to buy Armo Biosciences for $1.6 billion to bolster cancer pipeline". Reuters. Archived from the original on 9 June 2018.
"Lilly Continues Oncology Expansion with Plans to Buy AurKa Pharma for Up to $575M". Genetic Engineering & Biotechnology News. 14 May 2018. Archived from the original on 12 June 2018.
"Eli Lilly Deepens its Oncology Offerings with an $8 Billion Acquisition of Loxo Oncology". 7 January 2019. Archived from the original on 8 January 2019. Retrieved 7 January 2019.
"Lilly Announces Agreement to Acquire Loxo Oncology". 7 January 2019. Archived from the original on 8 January 2019. Retrieved 7 January 2019.
Burger, Ludwig (20 August 2019). "Elanco to buy Bayer's animal health unit for $7.6 billion". Reuters. Archived from the original on 20 August 2019.
"Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion". BioSpace. Archived from the original on 17 July 2020. Retrieved 17 July 2020.
"Lilly Announces Agreement to Acquire Dermira". BioSpace. Archived from the original on 17 July 2020. Retrieved 17 July 2020.
"Lilly Completes Acquisition of Dermira". BioSpace. Archived from the original on 3 March 2020. Retrieved 3 March 2020.
"Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans". Lilly. 1 June 2020. Archived from the original on 4 June 2020. Retrieved 4 June 2020.
Herper, Matthew (7 October 2020). "Eli Lilly says its monoclonal antibody cocktail is effective against Covid-19". Stat News. Archived from the original on 8 October 2020.
Thomas, Katie (8 October 2020). "Regeneron Asks F.D.A. for Emergency Approval for Drug That Trump C7laimed Cured Him". The New York Times. ISSN 0362-4331. Archived from the original on 8 October 2020.
"Lilly Announces Agreement to Acquire Disarm Therapeutics". BioSpace. 15 October 2020. Archived from the original on 8 May 2021.
"Lilly Statement Regarding NIH's ACTIV-3 Clinical Trial". Eli Lilly and Company (Press release). 26 October 2020. Archived from the original on 16 January 2021. Retrieved 26 October 2020.
"Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19". U.S. Food and Drug Administration (FDA) (Press release). 9 November 2020. Archived from the original on 11 January 2021.
"Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab". Food and Drug Administration (FDA) (Press release). 16 April 2021. Archived from the original on 16 April 2021. This article incorporates text from this source, which is in the public domain.
"Lilly, Innovent's Tyvyt nabs FDA review in front-line lung cancer. Could price pressure finally reach the PD-1/L1 class?". Fierce Pharma. 18 May 2021. Archived from the original on 20 August 2021. Retrieved 23 April 2022.
"Lilly Announces Acquisition of Protomer Technologies". 14 July 2021. Archived from the original on 17 July 2021. Retrieved 17 July 2021.
"US pauses distribution of Regeneron, Lilly antibodies over omicron concerns". Industry Dive. Archived from the original on 18 January 2022. Retrieved 18 January 2022.
Kelley, Lora (6 August 2022). "Major Indiana Employers Criticize State's New Abortion Law". The New York Times. ISSN 0362-4331. Archived from the original on 7 August 2022. Retrieved 7 August 2022.
"Eli Lilly to buy gene therapy company Akouos for $487 mln". Reuters. 18 October 2022. Archived from the original on 19 October 2022.
"Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout | BioSpace". 18 October 2022. Archived from the original on 20 October 2022. Retrieved 19 October 2022.
Gardner, Jonathan (14 December 2022). "Lilly lays out ambitious plans for 2023". BiopharmaDive. Archived from the original on 15 December 2022. Retrieved 14 December 2022.
"Donor Wall". Northern Ontario School of Medicine. Archived from the original on 19 June 2022. Retrieved 1 July 2022.
"Donor Listing". University of Toronto. Archived from the original on 30 May 2022. Retrieved 1 July 2022.
"Presidents' Circle Member Listing". University of Toronto. 1 May 2022. Archived from the original on 16 May 2022. Retrieved 1 July 2022.
"Honor Roll of Donors" (PDF). University of Washington; Amazon Web Services. October 2020. Archived (PDF) from the original on 10 June 2022. Retrieved 10 June 2022.
"Our Funders". National Press Foundation. 2013. Archived from the original on 28 January 2013. Retrieved 1 July 2022.
"Members". AdvaMed. 2014. Archived from the original on 13 July 2014. Retrieved 1 July 2022.
"Thank you to our donors" (PDF). Centre for Addiction and Mental Health. 2021. Archived (PDF) from the original on 19 June 2022. Retrieved 1 July 2022.
"2020-21 SickKids Annual Report". SickKids Foundation. 2021. Archived from the original on 20 June 2022. Retrieved 1 July 2022.
"The 8th Princess Margaret Hospital Conference: Developments in Cancer Management". FDocuments India. Archived from the original on 20 June 2022. Retrieved 1 July 2022.
"2021 Annual Report" (PDF). Princess Margaret Cancer Foundation. 2021. Archived (PDF) from the original on 20 November 2021. Retrieved 1 July 2022.
"Our Donors". Scarborough Health Network Foundation. 2021. Archived from the original on 20 June 2022. Retrieved 1 July 2022.
"Donor List - Cumulative". Sinai Health Annual Report. 31 March 2021. Archived from the original on 20 June 2022. Retrieved 1 July 2022.
"Our donors - Your Impact". Sunnybrook Foundation. 2022. Archived from the original on 20 June 2022. Retrieved 1 July 2022.
"2020 Donors". FNIH 2020 Annual Report. Archived from the original on 2 April 2022. Retrieved 6 April 2022.
"Consultant Lobbyist Registration No. CL4899-20200917025456". Office of the Integrity Commissioner of Ontario. 22 September 2021. Archived from the original on 8 March 2022. Retrieved 8 March 2022.
"Companies". International Federation of Pharmaceutical Manufacturers and Associations. Archived from the original on 1 July 2022. Retrieved 1 July 2022.
"Our Members". National Health Council. Archived from the original on 6 April 2022. Retrieved 6 April 2022.
"Eli Lilly division to buy Monsanto's cow growth hormone business for $300M". www.bizjournals.com. 20 August 2008. Archived from the original on 1 August 2022. Retrieved 19 March 2022.
"Monsanto to divest bovine growth hormone". www.bizjournals.com. 6 August 2008. Archived from the original on 29 June 2018. Retrieved 23 March 2022.
"Eli Lilly files motion to prevent giving 340B drug discounts to contract pharmacies". Healthcare Finance News. 25 May 2021. Archived from the original on 7 July 2021. Retrieved 20 March 2022.
"Lilly.com". Eli Lilly and Company. Archived from the original on 1 August 2022. Retrieved 20 March 2022.
"Eli Lilly Again Reports Big Revenue Gains From 340B Denials". 340binformed.org. 1 November 2021. Archived from the original on 20 October 2022. Retrieved 20 March 2022.
Wolfson, Andrew. "Prozac maker paid millions to secure favorable verdict in mass shooting lawsuit, victims say". USA TODAY. Archived from the original on 20 October 2022. Retrieved 20 March 2022.
"Prozac Litigation - Link to Suicide, Birth Defects & Class Action". Drugwatch.com. Archived from the original on 21 March 2022. Retrieved 20 March 2022.
Angier, Natalie (16 August 1990). "HEALTH; Eli Lilly Facing Million-Dollar Suits On Its Antidepressant Drug Prozac". The New York Times. ISSN 0362-4331. Archived from the original on 20 March 2022. Retrieved 20 March 2022.
"Eli Lilly in storm over Prozac evidence". Financial Times. 30 December 2004. Archived from the original on 20 March 2022. Retrieved 20 March 2022.
"Suicidality in Children and Adolescents Being Treated With Antidepressant Medications". FDA. 3 November 2018. Archived from the original on 23 August 2020.
Berenson A (5 January 2007). "Lilly Settles With 18,000 Over Zyprexa". The New York Times. Archived from the original on 19 February 2017. Retrieved 20 March 2022.
Berenson A (4 January 2007). "Mother Wonders if Psychosis Drug Helped Kill Son". The New York Times. Archived from the original on 1 September 2012. Retrieved 21 May 2013.
Pagnamenta, Robin (23 January 2007). "Eli Lilly was concerned by Zyprexa side-effects from 1998". The Times. Archived from the original on 20 February 2007.
Berenson A (26 March 2008). "Lilly Settles Alaska Suit Over Zyprexa". The New York Times. Archived from the original on 15 February 2017. Retrieved 2 August 2022.
Harris G, Berenson A (14 January 2009). "Lilly Said to Be Near $1.4 Billion U.S. Settlement". The New York Times. Archived from the original on 19 February 2017. Retrieved 2 August 2022.
"Eli Lilly settles Zyprexa lawsuit for $1.42 billion". NBC News. Associated Press. 15 January 2009. Archived from the original on 23 August 2022.
Wilson, Duff (2 October 2010). "Side Effects May Include Lawsuits". The New York Times. Archived from the original on 25 April 2011. Retrieved 23 September 2011.
Berenson, Alex (15 March 2008). "Eli Lilly E-Mail Discussed Unapproved Use of Drug". The New York Times. Archived from the original on 1 August 2022. Retrieved 24 August 2015.
Gottstein, James (2021). The Zyreza Papers. Samizdat Health Writer's Cooperative 2021. https://thezyprexapapers.com/ Archived 4 April 2022 at the Wayback Machine. Retrieved 21-10-26.
"The Fight for Pharma Accountability and Psychiatric Rights: Jim Gottstein, Esq". Psychiatric Times. 2 August 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
"Eli Lilly is Facing a Lawsuit Alleging A 'Sexually Hostile Work Environment' from a Former Lobbyist". Forbes. Archived from the original on 1 August 2022. Retrieved 20 March 2022.
Higgins-Dunn, Noah (30 June 2021). "Amid rush of scandals, Eli Lilly settles sex discrimination, harassment suit with former lobbyist". Fierce Pharma. Archived from the original on 30 June 2021. Retrieved 20 March 2022.
Terrell, Kenneth. "Older Workers Sue Eli Lilly for Age Discrimination". AARP. Archived from the original on 1 August 2022. Retrieved 20 March 2022.
Stastna, Kazi (13 September 2013). "Eli Lilly files $500M NAFTA suit against Canada over drug patents". CBC News. Archived from the original on 26 March 2015.
"#05-685: 12-21-05 Eli Lilly and Company to Pay U.S. $36 Million Relating to Off-Label Promotion". www.justice.gov. Archived from the original on 20 March 2022. Retrieved 20 March 2022.
Abutaleb, Yasmeen (30 January 2019). "U.S. lawmakers request info from insulin makers on rising prices". Reuters. Archived from the original on 31 January 2019.
Jiang, Kevin (11 November 2022). "Eli Lilly loses billions in market cap after 'verified' Twitter impostor promises free insulin". Toronto Star. Archived from the original on 14 November 2022. Retrieved 14 November 2022.
Lee, Bruce Y. (12 November 2022). "Fake Eli Lilly Twitter Account Claims Insulin Is Free, Stock Falls 4.37%". Forbes. Archived from the original on 14 November 2022.
Dellatto, Marisa (10 November 2022). "Eli Lilly Clarifies It's Not Offering Free Insulin After Tweet From Fake Verified Account—As Chaos Unfolds On Twitter". Forbes. Archived from the original on 14 November 2022.

whcbc.org (Global: low place; English: low place)

"Confirmed Keynotes". Wharton School.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Kahn, E. J. (1975). All In A Century: The First 100 Years of Eli Lilly and Company. West Cornwall, CT. p. 23. OCLC 5288809.{{cite book}}: CS1 maint: location missing publisher (link)
Nicolaou, Kyriacos C.; Rigol, Stephan (1 February 2018). "A brief history of antibiotics and select advances in their synthesis". The Journal of Antibiotics. 71 (2): 153–184. doi:10.1038/ja.2017.62. ISSN 1881-1469. PMID 28676714.
Thomas, Katie (8 October 2020). "Regeneron Asks F.D.A. for Emergency Approval for Drug That Trump C7laimed Cured Him". The New York Times. ISSN 0362-4331. Archived from the original on 8 October 2020.
Kelley, Lora (6 August 2022). "Major Indiana Employers Criticize State's New Abortion Law". The New York Times. ISSN 0362-4331. Archived from the original on 7 August 2022. Retrieved 7 August 2022.
Angier, Natalie (16 August 1990). "HEALTH; Eli Lilly Facing Million-Dollar Suits On Its Antidepressant Drug Prozac". The New York Times. ISSN 0362-4331. Archived from the original on 20 March 2022. Retrieved 20 March 2022.

wsj.com (Global: 79^th place; English: 65^th place)

Hagerty, James R. (3 May 2020). "Eli Lilly CEO Richard Wood Oversaw Prozac Launch". The Wall Street Journal. Archived from the original on 23 May 2020.
Glickman, Lauren Thomas, Jonathan D. Rockoff and Ben (6 January 2026). "Exclusive | Eli Lilly Nears Deal for Biotech Ventyx". The Wall Street Journal. Retrieved 7 January 2026.{{cite web}}: CS1 maint: multiple names: authors list (link)

Eli Lilly and Company (English Wikipedia)

340binformed.org (Global: low place; English: low place)

aarp.org (Global: 4,682nd place; English: 2,794th place)

adweek.com (Global: 1,117th place; English: 624th place)

amazonaws.com (Global: 5,409th place; English: 3,407th place)

uw-s3-cdn.s3.us-west-2.amazonaws.com

amgen.com (Global: low place; English: low place)

archive.org (Global: 6th place; English: 6th place)

archive.today (Global: 14th place; English: 14th place)

arthritisaustralia.com.au (Global: low place; English: low place)

axios.com (Global: 1,716th place; English: 973rd place)

biopharmadive.com (Global: low place; English: low place)

biospace.com (Global: low place; English: 7,595th place)

bizjournals.com (Global: 407th place; English: 241st place)

books.google.com (Global: 3rd place; English: 3rd place)

britannica.com (Global: 40th place; English: 58th place)

camh.ca (Global: low place; English: low place)

cbc.ca (Global: 115th place; English: 82nd place)

cbsnews.com (Global: 108th place; English: 80th place)

citeline.com (Global: low place; English: low place)

insights.citeline.com

clarah.co (Global: low place; English: low place)

cnbc.com (Global: 220th place; English: 155th place)

cnn.com (Global: 28th place; English: 26th place)

edition.cnn.com

congress.gov (Global: 730th place; English: 468th place)

defense.gov (Global: 1,038th place; English: 668th place)

media.defense.gov

dhs.gov (Global: 4,767th place; English: 3,136th place)

diabetes.ca (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

drugwatch.com (Global: low place; English: low place)

elanco.com (Global: low place; English: low place)

investor.elanco.com

endocrine.org (Global: low place; English: low place)

endpts.com (Global: low place; English: low place)

escardio.org (Global: low place; English: low place)

europa.eu (Global: 68th place; English: 117th place)

imi.europa.eu

fda.gov (Global: 447th place; English: 338th place)

fdocuments.in (Global: low place; English: low place)

fiercebiotech.com (Global: low place; English: 8,828th place)

fiercepharma.com (Global: low place; English: 8,921st place)

financialpost.com (Global: 3,491st place; English: 1,999th place)

fnih.org (Global: low place; English: low place)

2020-annual-report.fnih.org

forbes.com (Global: 54th place; English: 48th place)

ford.com (Global: 2,073rd place; English: 1,349th place)

media.ford.com

fortune.com (Global: 433rd place; English: 284th place)

ft.com (Global: 210th place; English: 157th place)

genengnews.com (Global: low place; English: 6,625th place)

healthcarefinancenews.com (Global: low place; English: low place)

hematology.org (Global: low place; English: low place)

hopeww.org (Global: low place; English: low place)

ifpma.org (Global: low place; English: low place)

in.gov (Global: 3,146th place; English: 1,695th place)

in.gov

secure.in.gov

independent.co.uk (Global: 36th place; English: 33rd place)

indianahistory.org (Global: low place; English: low place)

indystar.com (Global: 1,646th place; English: 896th place)

informa.com (Global: low place; English: low place)

scrip.pharmaintelligence.informa.com

innovativemedicines.ca (Global: low place; English: low place)

issuu.com (Global: 537th place; English: 476th place)

iu.edu (Global: 3,316th place; English: 1,982nd place)

tobiascenter.iu.edu

jdrf.ca (Global: low place; English: low place)

jstor.org (Global: 26th place; English: 20th place)

justice.gov (Global: 918th place; English: 556th place)

kpcnews.com (Global: low place; English: low place)

latimes.com (Global: 22nd place; English: 19th place)

lilly.com (Global: low place; English: low place)

investor.lilly.com

lilly.com

lobbycanada.gc.ca (Global: low place; English: low place)

macleans.ca (Global: 1,824th place; English: 1,065th place)

marketwatch.com (Global: 1,303rd place; English: 808th place)

nationalhealthcouncil.org (Global: low place; English: low place)

aarp.org (Global: 4,682^nd place; English: 2,794^th place)

adweek.com (Global: 1,117^th place; English: 624^th place)

amazonaws.com (Global: 5,409^th place; English: 3,407^th place)

archive.org (Global: 6^th place; English: 6^th place)

archive.today (Global: 14^th place; English: 14^th place)

axios.com (Global: 1,716^th place; English: 973^rd place)

biospace.com (Global: low place; English: 7,595^th place)

bizjournals.com (Global: 407^th place; English: 241^st place)

books.google.com (Global: 3^rd place; English: 3^rd place)

britannica.com (Global: 40^th place; English: 58^th place)

cbc.ca (Global: 115^th place; English: 82^nd place)

cbsnews.com (Global: 108^th place; English: 80^th place)

cnbc.com (Global: 220^th place; English: 155^th place)

cnn.com (Global: 28^th place; English: 26^th place)

congress.gov (Global: 730^th place; English: 468^th place)

defense.gov (Global: 1,038^th place; English: 668^th place)

dhs.gov (Global: 4,767^th place; English: 3,136^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

europa.eu (Global: 68^th place; English: 117^th place)

fda.gov (Global: 447^th place; English: 338^th place)

fiercebiotech.com (Global: low place; English: 8,828^th place)

fiercepharma.com (Global: low place; English: 8,921^st place)

financialpost.com (Global: 3,491^st place; English: 1,999^th place)

forbes.com (Global: 54^th place; English: 48^th place)

ford.com (Global: 2,073^rd place; English: 1,349^th place)

fortune.com (Global: 433^rd place; English: 284^th place)

ft.com (Global: 210^th place; English: 157^th place)

genengnews.com (Global: low place; English: 6,625^th place)

in.gov (Global: 3,146^th place; English: 1,695^th place)

independent.co.uk (Global: 36^th place; English: 33^rd place)

indystar.com (Global: 1,646^th place; English: 896^th place)

issuu.com (Global: 537^th place; English: 476^th place)

iu.edu (Global: 3,316^th place; English: 1,982^nd place)

jstor.org (Global: 26^th place; English: 20^th place)

justice.gov (Global: 918^th place; English: 556^th place)

latimes.com (Global: 22^nd place; English: 19^th place)

macleans.ca (Global: 1,824^th place; English: 1,065^th place)

marketwatch.com (Global: 1,303^rd place; English: 808^th place)

nbcnews.com (Global: 137^th place; English: 101^st place)

nih.gov (Global: 4^th place; English: 4^th place)

nytimes.com (Global: 7^th place; English: 7^th place)

opensecrets.org (Global: 4,705^th place; English: 2,665^th place)

ourcommons.ca (Global: low place; English: 8,086^th place)

prnewswire.com (Global: 406^th place; English: 258^th place)

psychiatrictimes.com (Global: 9,815^th place; English: 7,507^th place)

reuters.com (Global: 49^th place; English: 47^th place)

sciencehistory.org (Global: 3,963^rd place; English: 2,357^th place)

seattlepi.com (Global: 1,215^th place; English: 726^th place)

seattletimes.com (Global: 519^th place; English: 316^th place)

sec.gov (Global: 572^nd place; English: 436^th place)

statnews.com (Global: 8,771^st place; English: 5,253^rd place)

theguardian.com (Global: 12^th place; English: 11^th place)

thestar.com (Global: 336^th place; English: 216^th place)

upi.com (Global: 290^th place; English: 202^nd place)

usatoday.com (Global: 41^st place; English: 34^th place)

utoronto.ca (Global: 1,601^st place; English: 1,117^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 5^th place; English: 5^th place)

wsj.com (Global: 79^th place; English: 65^th place)